EGFR and glioblastoma: Although such tumors lacked necrosis or microvascular proliferation, they harbored molecular features consistent with GBM, including TERT promotor mutation, EGFR amplification, and/or a combined chromosome 7 gain and chromosome 10 loss (+ 7/-10) [1, 2].